Newsroom | 3024 results

Sorted by: Latest

Veterinary
-

Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; Initiates Fiscal Year 2027 Guidance

CHICAGO--(BUSINESS WIRE)--Covista Inc. (NYSE: CVSA), America’s largest healthcare educator, today reported fourth quarter and fiscal year 2026 results (ended June 30, 2026). The Company completed its three-year Growth with Purpose strategy and now embarks on its Purpose at Scale strategy, leading the transformation of higher education by training the next generation of healthcare professionals at an industry-leading scale. "We completed Growth with Purpose in a position of strength, exceeding b...
-

New Multi-Center Study Shows equicenta® CTM, Ready-to-Use, Equine Umbilical Cord Allograft Outperforms Standard of Care in Returning Performance Horses to Work

AUSTIN, Texas--(BUSINESS WIRE)--Equine Performance Labs (EPL), the team behind equicenta® CTM — announced the publication of a peer-reviewed, prospective, controlled clinical trial demonstrating that a single, ready-to-use injection of equicenta® CTM produced significantly better clinical outcomes than clinician-selected standard of care (SOC) in lame performance horses. The study was accepted June 29, 2026 in Frontiers in Veterinary Science (Veterinary Regenerative Medicine section) and repres...
-

Zoetis Announces Second Quarter 2026 Results

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE:ZTS), the world's leading animal health company, today reported its financial results for the second quarter of 2026. The company reported revenue of $2.5 billion for the second quarter of 2026, flat compared with the second quarter of 2025, decreasing 1% on an organic operational1 basis. Net income for the second quarter of 2026 was $691 million, or $1.65 per diluted share, decreasing 5% and growing 1%, respectively, on a reported basis. Adj...
-

Zoetis Appoints Jay Saccaro as Chief Financial Officer and Chief Operating Officer

PARSIPPANY, N.J.--(BUSINESS WIRE)--Zoetis Inc. (NYSE: ZTS) today announced the appointment of James (Jay) Saccaro as Executive Vice President, Chief Financial Officer and Chief Operating Officer, effective August 17, 2026. In this newly created role, Mr. Saccaro will lead Zoetis’ global finance function, shaping capital allocation, financial strategy, reporting and controls, and investor engagement and oversee Global Manufacturing and Supply to drive operational execution and performance. With...
-

Greycoat Research Brings ‘Cat Kidney Store’ to SUPERZOO 2026 as U.S. Sales Surge 8.5-fold

LAS VEGAS--(BUSINESS WIRE)--Greycoat Research, a cat kidney care brand in South Korea, will unveil its Cat Kidney Store and AIM products at SUPERZOO 2026 in Las Vegas....
-

Kindred Companion Sciences Unveils First Dogs Genetically Edited to Remove the Major Dog Allergen

NEW YORK--(BUSINESS WIRE)--Kindred Companion Sciences, a biotechnology company applying precision gene editing in companion animals, emerged from stealth today with a research publication in The CRISPR Journal. The peer-reviewed study, “Targeted genetic knockout of Can f 1, the major allergen in dogs,” describes a precise CRISPR-Cas9 edit in two female beagles, Alfie and Bailey. Born in September 2024, the dogs have shown healthy growth and development, and Can f 1 protein was not detected in s...
-

IDEXX Laboratories Announces Second Quarter Results

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced second quarter results. Second Quarter Results The Company reports revenues of $1,217 million for the second quarter of 2026, an increase of 10% as reported and 9% organic, driven by Companion Animal Group ("CAG") growth of 9% as reported and organic, Water revenue growth of 15% as reported and 13% organic, and LPD revenue growth of 11% as reported and 9% org...
-

Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results; Highlights Key Regulatory and Clinical Milestones Across Broad, Diverse Pipeline

RAHWAY, N.J.--(BUSINESS WIRE)--Merck & Co., Inc., Rahway, N.J., USA Announces Second-Quarter 2026 Financial Results...
-

Best’s Market Segment Report: US Pet Insurance Plans Show Rapid and Profitable Growth

OLDWICK, N.J.--(BUSINESS WIRE)--Despite low market penetration, pet health insurance is one of the fastest-growing lines in the property/casualty industry, averaging approximately 20% annual growth since the COVID-19 pandemic, according to a new AM Best report.The Best’s Market Segment Report, “US Pet Insurance Plans: First View Shows Rapid and Profitable Growth,” finds that the segment’s net combined ratio under the breakeven point in 2024 and 2025 signified profitable underwriting for the segm...
-

Central Garden & Pet to Participate in Investor Conferences

WALNUT CREEK, Calif.--(BUSINESS WIRE)--Central Garden & Pet Company (NASDAQ: CENT) (NASDAQ: CENTA), a leading consumer goods company in the pet and garden industries, today announced that it will participate in the following upcoming investor conferences: CG 46th Annual Growth Conference (August 11) Boston, Mass. – Niko Lahanas, Chief Executive Officer, will participate in a fireside chat at 10:30 a.m. ET. Senior management will also host one-on-one meetings with institutional investors. Ba...